A recent businesswire article discussed the latest product to receive the FDA’s coveted emergency use authorization. The Detect COVID-19 test from Detect™, Inc. will be available for over-the-counter home use in the coming weeks. The cost will be under $50, which makes it the lowest priced at-home molecular test available to consumers. The test will also be used for regular screening programs in school and workplaces.
The Detect test is meant to work in unison with a proprietary app that gives users instructions on how to perform the test and interpret their results. Detect is also developing an electronic travel pass system with an add-on telehealth service so that their test may be used for travel and event entry. As a vote of confidence, Detect received an $8.1 million contract to increase manufacturing from the NIH Rapid Acceleration of Diagnostics Initiative.
